Rapamycin: The Easter Island Discovery
Rapamycin is a compound originally found in soil bacteria on Easter Island that's now being studied as one of the most promising anti-aging drugs we have. Doctors already use it to prevent organ transplant rejection, but researchers discovered something unexpected—it appears to slow aging itself. In animals, it's extended lifespan by around 10%, which is huge in longevity science, and it's now in human trials for age-related diseases.
Here's how it works inside your body. Your cells have a growth control system called mTOR, which you can think of as your body's accelerator pedal—it tells cells when to grow and build new proteins. Rapamycin hits the brakes on this system by binding to a helper protein and blocking mTOR. When growth slows down, your cells shift into maintenance mode instead. This triggers your cells to clean house more thoroughly, clearing out damaged parts and old debris through a process called autophagy. It's like forcing your body to do deep cleaning instead of constantly expanding.
This metabolic shift mimics what happens when you eat less food, which we know extends lifespan. By putting cells in this repair-focused state, rapamycin seems to make your body more resilient and resistant to aging. Researchers are now testing lower, more frequent doses to capture these longevity benefits while minimizing other effects.
Dosage Information
Typical Dose
1-6 mg weekly (longevity protocols)
Frequency
Once weekly (longevity use) or daily (transplant immunosuppression)
Administration
Oral tablet
Half-Life
62 hours
Notes
Longevity dosing protocols are not FDA-approved. Weekly intermittent dosing is used in research contexts to minimize side effects. Requires medical supervision and monitoring of lipid levels and immune function.
Why this matters
Long half-life; intermittent dosing (weekly) is preferred for longevity protocols to avoid immunosuppression.
Protocol cycle
Where does Rapamycin sit?
See how this peptide compares across all 150 peptides in our database.
Evidence Score
0.68
Compound Data
Molecular Formula
C51H79NO13
Molecular Weight
914.20 g/mol
IUPAC Name
(1R,9S,12S,15R,16E,18R,19R,21R,23S,24E,26E,28E,30S,32S,35R)-1,18-dihydroxy-12-[(2R)-1-[(1S,3R,4R)-4-hydroxy-3-methoxycyclohexyl]propan-2-yl]-19,30-dimethoxy-15,17,21,23,29,35-hexamethyl-11,36-dioxa-4-azatricyclo[30.3.1.04,9]hexatriaconta-16,24,26,28-tetraene-2,3,10,14,20-pentone
PubChem CID
5284616Potential Side Effects
Rapamycin discussions
Quick Facts
- Administration
- Oral tablet
- Typical Dose
- 1-6 mg weekly (longevity protocols)
- Frequency
- Once weekly (longevity use) or daily (transplant immunosuppression)
- References
- 0 curated + 49 from PubMed
- Clinical Trials
- 49 registered
- Evidence Score
- 0.7 / 100
Frequently Asked Questions about Rapamycin
What is Rapamycin?
Rapamycin (Sirolimus) is a macrolide compound originally discovered in soil bacteria from Easter Island (Rapa Nui) that functions as a potent mTOR inhibitor. It is FDA-approved as an immunosuppressant for organ transplantation and has been investigated extensively in longevity research after demonstrating lifespan extension in multiple model organisms including mice — the most robust pharmacological longevity intervention identified to date. It is currently in human clinical trials for aging-related conditions through the Interventions Testing Program and multiple academic centers. Rapamycin sits at the center of modern longevity science.
How does Rapamycin work?
Rapamycin works by forming a complex with the intracellular protein FKBP12, which then binds to and inhibits mTORC1 — the mechanistic target of rapamycin complex 1. mTORC1 is a master regulator of cell growth, protein synthesis, and autophagy. By inhibiting mTORC1, rapamycin shifts cellular metabolism from growth mode to maintenance and repair mode, enhancing autophagy (cellular self-cleaning), reducing senescent cell accumulation, and improving stress resistance. These effects closely mimic the longevity-promoting effects of caloric restriction at the molecular level. In animal models, rapamycin extended median lifespan by 9-14% even when started late in life. Partial mTOR inhibition through intermittent dosing is being investigated to capture longevity benefits while minimizing immunosuppressive side effects.
What is the recommended dosage for Rapamycin?
The typical dose is 1-6 mg weekly (longevity protocols). Once weekly (longevity use) or daily (transplant immunosuppression). Administration: Oral tablet. Longevity dosing protocols are not FDA-approved. Weekly intermittent dosing is used in research contexts to minimize side effects. Requires medical supervision and monitoring of lipid levels and immune function.
What are the side effects of Rapamycin?
Immunosuppression — increased infection risk (dose-dependent). Hyperlipidemia — elevated triglycerides and cholesterol (common). Mouth sores (common at daily dosing, uncommon at weekly). Impaired wound healing (uncommon). Glucose intolerance (uncommon). Thrombocytopenia (uncommon)
What is the Rapamycin cycle protocol?
Rapamycin is typically cycled ongoing. Weekly intermittent dosing for longevity research
Questions reflect common community inquiries. This is not medical advice.